Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia

Nature Medicine volume 12, pages 1191–1197 (2006)Cite this article

An Erratum to this article was published on 01 November 2006

This article has been updated

Abstract

We demonstrate here that lymphoid enhancer-binding factor 1 (LEF-1) mediates the proliferation, survival and differentiation of granulocyte progenitor cells. We initially documented the importance of this transcription factor in the bone marrow of individuals with severe congenital neutropenia (CN) with a 'differentiation block' at the promyelocytic stage of myelopoiesis1. LEF-1 expression was greatly reduced or even absent in CN arrested promyelocytes, resulting in defective expression of the LEF-1 target genes CCND1, MYC and BIRC5, encoding cyclin D1 (ref. 2), c-Myc3 and survivin4, respectively. In contrast, healthy individuals showed highest LEF-1 expression in promyelocytes. Reconstitution of LEF-1 in early hematopoietic progenitors of two individuals with CN corrected the defective myelopoiesis and resulted in the differentiation of these progenitors into mature granulocytes. Repression of endogenous LEF-1 by specific short hairpin RNA inhibited proliferation and induced apoptosis of CD34+ progenitors from healthy individuals and of cells from two myeloid lines (HL-60 and K562). C/EBPα, a key transcription factor in granulopoiesis5,6, was directly regulated by LEF-1. These observations indicate that LEF-1 is an instructive factor regulating neutrophilic granulopoiesis whose absence plays a critical role in the defective maturation program of myeloid progenitors in individuals with CN. NOTE: In the version of this article initially published, the DOI was incorrect. The correct DOI is 10.1038/nm1474. The error has been corrected in the HTML and PDF versions of the article.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Expression of LEF-1 and LEF-1 target genes is abrogated in CN myeloid precursors and is upregulated in LEF-1–rescued CN CD34+ cells.
Figure 2: Restoration of defective LEF-1 expression promotes granulocytic differentiation of CN CD34+ progenitors.
Figure 3: Anti-proliferative and pro-apoptotic effects of LEF-1 inhibition in CD34+ progenitors.
Figure 4: LEF-1 overexpression in CD34+ cells promoted upregulation of LEF-1 target genes and increased cell proliferation.

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

Change history

  • 19 October 2006

    In the version of this article initially published, the DOI was incorrect. The correct DOI is 10.1038/nm1474. The error has been corrected in the HTML and PDF versions of the article.

References

  1. Welte, K., Zeidler, C. & Dale, D.C. Severe congenital neutropenia. Semin. Hematol. 43, 189–195 (2006).

    Article  CAS  Google Scholar 

  2. Shtutman, M. et al. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl Acad. Sci. USA 96, 5522–5527 (1999).

    Article  CAS  Google Scholar 

  3. He, T.C. et al. Identification of c-Myc as a target of the APC pathway. Science 281, 1509–1512 (1998).

    Article  CAS  Google Scholar 

  4. Kim, P.J., Plescia, J., Clevers, H., Fearon, E.R. & Altieri, D.C. Survivin and molecular pathogenesis of colorectal cancer. Lancet 362, 205–209 (2003).

    Article  CAS  Google Scholar 

  5. Radomska, H.S. et al. CCAAT/enhancer binding protein α is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol. Cell. Biol. 18, 4301–4314 (1998).

    Article  CAS  Google Scholar 

  6. Zhang, P. et al. Induction of granulocytic differentiation by 2 pathways. Blood 99, 4406–4412 (2002).

    Article  CAS  Google Scholar 

  7. Rosenberg, P.S. et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 107, 4628–4635 (2006).

    Article  CAS  Google Scholar 

  8. Konishi, N. et al. Defective proliferation of primitive myeloid progenitor cells in patients with severe congenital neutropenia. Blood 94, 4077–4083 (1999).

    CAS  PubMed  Google Scholar 

  9. Cario, G. et al. Heterogeneous expression pattern of pro- and anti-apoptotic factors in myeloid progenitor cells of patients with severe congenital neutropenia treated with granulocyte colony-stimulating factor. Br. J. Haematol. 129, 275–278 (2005).

    Article  Google Scholar 

  10. Dale, D.C. et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 96, 2317–2322 (2000).

    CAS  Google Scholar 

  11. Dong, F. et al. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N. Engl. J. Med. 333, 487–493 (1995).

    Article  CAS  Google Scholar 

  12. Person, R.E. et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat. Genet. 34, 308–312 (2003).

    Article  CAS  Google Scholar 

  13. Devriendt, K. et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat. Genet. 27, 313–317 (2001).

    Article  CAS  Google Scholar 

  14. van de Wetering, M., de Lau, W. & Clevers, H. WNT signaling and lymphocyte development. Cell 109 (Suppl.), 13–19 (2002).

    Article  Google Scholar 

  15. Nawshad, A. & Hay, E.D. TGFβ3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development. J. Cell Biol. 163, 1291–1301 (2003).

    Article  CAS  Google Scholar 

  16. Ross, D.A. & Kadesch, T. The notch intracellular domain can function as a coactivator for LEF-1. Mol. Cell. Biol. 21, 7537–7544 (2001).

    Article  CAS  Google Scholar 

  17. Merrill, B.J., Gat, U., DasGupta, R. & Fuchs, E. Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev. 15, 1688–1705 (2001).

    Article  CAS  Google Scholar 

  18. Hovanes, K. β-catenin–sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat. Genet. 28, 53–57 (2001).

    CAS  PubMed  Google Scholar 

  19. Giese, K., Kingsley, C., Kirshner, J.R. & Grosschedl, R. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9, 995–1008 (1995).

    Article  CAS  Google Scholar 

  20. Travis, A., Amsterdam, A., Belanger, C. & Grosschedl, R. LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor α enhancer function. Genes Dev. 5, 880–894 (1991).

    Article  CAS  Google Scholar 

  21. Hsu, S.-C., Galceran, J. & Grosschedl, R. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with β-catenin. Mol. Cell. Biol. 18, 4807–4818 (1998).

    Article  CAS  Google Scholar 

  22. Reya, T. et al. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 13, 15–24 (2000).

    Article  CAS  Google Scholar 

  23. Filali, M., Cheng, N., Abbott, D., Leontiev, V. & Engelhardt, J.F. Wnt-3A/β-catenin signaling induces transcription from the LEF-1 promoter. J. Biol. Chem. 277, 33398–33410 (2002).

    Article  CAS  Google Scholar 

  24. Timchenko, N. et al. Autoregulation of the human C/EBPα gene by stimulation of upstream stimulatory factor binding. Mol. Cell. Biol. 19, 1192–1202 (1995).

    Article  Google Scholar 

  25. Suh, H.C. et al. C/EBPα determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation. Blood 107, 4308–4316 (2006).

    Article  CAS  Google Scholar 

  26. Ross, S.E. et al. Phosphorylation of C/EBPα inhibits granulopoiesis. Mol. Cell. Biol. 24, 675–686 (2004).

    Article  CAS  Google Scholar 

  27. Cammenga, J. et al. Induction of C/EBPα activity alters gene expression and differentiation of human CD34+ cells. Blood 101, 2206–2214 (2003).

    Article  CAS  Google Scholar 

  28. Zhang, D.E. et al. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice. Proc. Natl. Acad. Sci. USA 94, 569–574 (1997).

    Article  CAS  Google Scholar 

  29. Pabst, T. et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPα), in acute myeloid leukemia. Nat. Genet. 27, 263–270 (2001).

    Article  CAS  Google Scholar 

  30. Radomska, H.S. et al. Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. J. Exp. Med. 203, 371–381 (2006).

    Article  CAS  Google Scholar 

  31. Welte, K. et al. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 75, 1056–1063 (1990).

    CAS  PubMed  Google Scholar 

  32. Harris, T.E., Albrecht, J.H., Nakanishi, M. & Darlington, G.J. CCAAT/enhancer-binding protein-α cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding. J. Biol. Chem. 276, 29200–29209 (2001).

    Article  CAS  Google Scholar 

  33. Johansen, L.M. c-Myc is a critical target for c/EBPα in granulopoiesis. Mol. Cell. Biol. 21, 3789–3806 (2001).

    Article  CAS  Google Scholar 

  34. Waterman, M.L. Lymphoid enhancer factor/T cell factor expression in colorectal cancer. Cancer Metastasis Rev. 23, 41–52 (2004).

    Article  CAS  Google Scholar 

  35. Liu, F., van den Broek, O., Destree, O. & Hoppler, S. Distinct roles for Xenopus Tcf/Lef genes in mediating specific responses to Wnt/β-catenin signalling in mesoderm development. Development 132, 5375–5385 (2005).

    Article  CAS  Google Scholar 

  36. Scherr, M., Battmer, K., Ganser, A. & Eder, M. Modulation of gene expression by lentiviral-mediated delivery of small interfering RNA. Cell Cycle 2, 251–257 (2003).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank M. Morgan for critically reading the manuscript; V. Bucan and D. Lan for sequencing, G. Asgedom and A. Müller-Brechlin for excellent technical assistance, and M. Ballmaier and C. Reimer for assistance in cell sorting. We also thank the study subjects and their families for cooperation. This work was supported by the German Network “Congenital Bone Marrow Failure Syndromes” of the Federal Ministry of Education and Research (BMBF), Deutsche Forschungsgemeinschaft (SFB 566), Madeleine-Schickedanz-Kinderkrebsstiftung, and José Carreras Leukämie-Stiftung e.V.

Author information

Author notes

  1. Gunnar Cario

    Present address: Department of Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, 24105, Kiel, Germany

  2. Gunnar Cario and Murat Uenalan: These authors contributed equally to this work.

Authors and Affiliations

  1. Departments of Pediatric Hematology and Oncology, Carl-Neuberg-Str. 1, Hannover, 30625, Germany

    Julia Skokowa, Gunnar Cario, Murat Uenalan, Axel Schambach, Manuela Germeshausen, Cornelia Zeidler, Martin Stanulla & Karl Welte

  2. Hematology, Hemostaseology and Oncology, Carl-Neuberg-Str. 1, Hannover, 30625, Germany

    Axel Schambach, Karin Battmer, Matthias Eder, Christopher Baum & Michaela Scherr

  3. Pathology, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany

    Ulrich Lehmann

  4. Department of Cellular and Molecular Immunology, Max Planck Institute of Immunobiology, Freiburg, 79108, Germany

    Rudolf Grosschedl

Authors
  1. Julia Skokowa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gunnar Cario
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Murat Uenalan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Axel Schambach
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Manuela Germeshausen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Karin Battmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Cornelia Zeidler
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ulrich Lehmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Matthias Eder
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Christopher Baum
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Rudolf Grosschedl
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Martin Stanulla
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Michaela Scherr
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Karl Welte
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

K.W., G.C., J.S. and M.St. made initial observations. J.S. designed and performed the main experiments, analyzed the data and wrote the manuscript. M.U. performed western blot analysis and wrote the manuscript. M.Sch., M.E. and K.B. designed shRNA constructs and transduced cells. A.S. and C.B. designed lv constructs that contained full-length LEF-1 or dnLEF-1 and produced viral supernatants. M.G. performed sequence analysis of ELA2 gene. C.Z. provided patients data. U.L. provided laser-assisted microscope. K.W. supervised experimentation, coordinated the project and wrote the manuscript.

Corresponding authors

Correspondence to Julia Skokowa or Karl Welte.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

mRNA expression of secretory granule proteins; LEF-1 mRNA/protein expression as well as TCF-3,-4 mRNA expression. (PDF 220 kb)

Supplementary Fig. 2

mRNA expression of indicated genes in sorted GFP− CD34+ CN cells from the LEF-1 lv and dnLEF-1 lv experiments. (PDF 26 kb)

Supplementary Fig. 3

mRNA expression of indicated genes in sorted RFP− cells from the shRNA transduction experiments. Morphology of LEF-1 and β-catenin shRNA transduced cells. (PDF 65 kb)

Supplementary Fig. 4

Effects of LEF-1 inhibition in two myeloid cell lines HL-60 and K562. (PDF 160 kb)

Supplementary Fig. 5

mRNA expression of indicated genes in sorted RFP− cells from the shRNA transduction experiments in K562 and HL-60 cell lines. (PDF 26 kb)

Supplementary Fig. 6

mRNA expression of indicated genes in sorted GFP− cells from the experiments in LEF-1 lv transduced CD34+ cells of healthy controls. (PDF 23 kb)

Supplementary Table 1

CN patients' characteristics and ELA2 mutations status. (PDF 15 kb)

Supplementary Table 2

Oligonucleotide sequences used for NoShift assay. (PDF 12 kb)

Supplementary Methods (PDF 106 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Skokowa, J., Cario, G., Uenalan, M. et al. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat Med 12, 1191–1197 (2006). https://doi.org/10.1038/nm1474

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1474

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing